Top grants help Sanford Research draw undergrad interns
Sanford Health is celebrating a big boost in grant funding to support an undergraduate research internship program that already draws top students from around the world.
Sanford Health is celebrating a big boost in grant funding to support an undergraduate research internship program that already draws top students from around the world.
Sanford Research has hit a key milestone in its efforts to gain FDA approval for ground-breaking use of stem cells in orthopedics and is already pursuing new trials to broaden its efforts.
Some of the most accomplished researchers in the medical world will be in Sioux Falls next week, and one will leave with the first $1 million prize awarded by Sanford Health.
Here’s good news for researchers at Sanford Health and the state’s bioscience economy: A major grant from the National Institutes of Health has been renewed five more years.
They reversed blindness, helped children walk and set the standard for all gene therapy trials. Meet the finalists for Sanford’s first $1 million Lorraine Cross Award.
A blood test developed by a Sanford Research scientist that uses a patient’s own immune system to help detect breast cancer has been licensed to Inanovate, a medical technology company specializing in screening and analysis of proteins.
Sanford Health is launching its second adipose-derived stem cell clinical trial – this one focusing on nonhealing leg wounds.
“This has not been done, and that’s why the Imagenetics team is attracting people from around the world.”
Biotech company Inanovate Inc. has named Sioux Falls its official headquarters and anticipates its operations in the city will increase in next two years.
Families whose children have Batten disease, a rare and deadly neurodegenerative disease, are feeling hope because of a clinical trial for a gene therapy developed in collaboration with researchers at Sanford Health.